Tuple, The Cloud Genomics CompanySupporting the Fight Against Cancer, Tuple Unveils Anti-PD-1 Antibodies Fully Designed by AIIn a preprint released on January 23, 2024, Tuple unveils its latest effort: designing antibodies using AI for the treatment of cancer.Jan 24
Research FeaturesFighting cancer with smart bullets: The antibody-drug conjugates revolutionAntibody-drug conjugates (ADCs) hold promise in cancer therapy, targeting malignant cells via a surface protein called the Epidermal Growth…Dec 27, 2023Dec 27, 2023
Amplitude VenturesReverb Therapeutics — Redirecting endogenous cytokinesLaunching Reverb Therapeutics out of stealth mode to redirect endogenous cytokines using antibodiesNov 15, 2023Nov 15, 2023
Cherifa Bochra SoltaniWhy is blood group important for blood transfusion?If you have a blood transfusion, it is vital that the blood you receive is well matched (compatible) with your own.Sep 15, 2023Sep 15, 2023
Tuple, The Cloud Genomics CompanySupporting the Fight Against Cancer, Tuple Unveils Anti-PD-1 Antibodies Fully Designed by AIIn a preprint released on January 23, 2024, Tuple unveils its latest effort: designing antibodies using AI for the treatment of cancer.Jan 24
Research FeaturesFighting cancer with smart bullets: The antibody-drug conjugates revolutionAntibody-drug conjugates (ADCs) hold promise in cancer therapy, targeting malignant cells via a surface protein called the Epidermal Growth…Dec 27, 2023
Amplitude VenturesReverb Therapeutics — Redirecting endogenous cytokinesLaunching Reverb Therapeutics out of stealth mode to redirect endogenous cytokines using antibodiesNov 15, 2023
Cherifa Bochra SoltaniWhy is blood group important for blood transfusion?If you have a blood transfusion, it is vital that the blood you receive is well matched (compatible) with your own.Sep 15, 2023
Amplitude VenturesRadiant BioTherapeutics — utilizing multabodies to transform antibody therapeuticsAnnouncing Radiant Biotherapeutics emerging out of stealth mode with $8M Seed Round and Two Pharma PartnershipsApr 25, 2023
Amplitude VenturesTentarix — creating next-generation multi-functional biologicsAnnouncing our lead investment into a $35M Series B financing of antibody developer TentarixSep 6, 2023
Jeffrey SweeneyUS Capital Global Engaged by PlantForm Corporation as Strategic Advisor on $25 Million Capital…US Capital Global has been engaged by Canadian biotech firm developing plant-made pharmaceuticals for exposure to chemical weapons, such as…Aug 31, 2023